6533b828fe1ef96bd1287a27

RESEARCH PRODUCT

Is a Vaginectomy Enough or is a Pelvic Exenteration Always Required for Surgical Treatment of Recurrent Cervical Cancer? A Propensity-Matched Study.

Filiberto ZattoniGabriella FerrandinaGabriella FerrandinaGiovanni ScambiaGiovanni ScambiaCarmine ConteAnna FagottiAnna FagottiAlfredo ErcoliMartina ArcieriLucia TortorellaNazario FoschiValerio GallottaGiuseppe VizzielliGiuseppe VizzielliVito Chiantera

subject

medicine.medical_specialtymedicine.medical_treatmentRecurrent cervical cancerUterine Cervical NeoplasmsResectionsColpotomyVaginectomy03 medical and health sciences0302 clinical medicineSurgical oncologyPregnancyMedicineHumansStage (cooking)Surgical treatmentGynecological MalignanciesRetrospective StudiesPelvic exenterationbusiness.industryGynecological Malignancies Resections Surgery UterineVaginectomyPerioperativeSurgeryPelvic ExenterationRadiation therapyUterineOncology030220 oncology & carcinogenesisQuality of Life030211 gastroenterology & hepatologySurgeryFemaleNeoplasm Recurrence Localbusiness

description

Purpose: Reporting the perioperative and survival outcomes of vaginectomy with respect to a matched series of pelvic exenteration (PE) in women with isolated recurrent cervical cancer. Methods: The records of vaginal recurrent cervical cancer patients admitted at Fondazione Policlinico “Agostino Gemelli” IRCCS in Rome from January 2010 to June 2019 were retrospectively analyzed. A propensity-matched score analysis was performed by age, clinical stage, disease-free interval, and R0 resection. Postsurgical complications and survival rates were evaluated. Results: Fifteen women underwent vaginectomy, and 30 patients were submitted to PE. No statistical differences were observed between the two groups at baseline characteristics. The vaginectomy procedures were successfully performed in all women, and no case required conversion to PE. Moreover, a higher rate of major postoperative complications after PE with respect to vaginectomy (p = 0.027) was recorded. Among them, three women required reoperation within 30 postoperative days, and four experienced two or more complications. Twenty-five (55.6%) women experienced recurrence: 8 of 25 (32.0%) in the vaginectomy group, and 17 of 25 (68%) in the PE group, with a median progression-free survival of 20 months and 13 months, respectively (p = 0.169). In total, 5 of 15 (33.3%) died of disease in the vaginectomy group and 13/30 (43.3%) in the PE group, with a median overall survival of 39 and 18 months for vaginectomy and PE, respectively (p = 0.161). Conclusions: The vaginectomy seems to allow for salvage treatment, such as radiotherapy and/or PE, but with a minimal impact on the quality of life in appropriately selected women with local recurrent cervical cancer.

10.1097/igc.0b013e3182a80aechttps://pubmed.ncbi.nlm.nih.gov/33063258